Abstract
In order to compare attitudes and management concerning hyperlipidaemia and risk factors for coronary heart disease among doctors in northern and in southern Europe, a questionnaire study was undertaken among doctors in primary health care and departments of internal medicine in Sicily and Stockholm. The regions differed in culture and health-care structure. Guidelines were similar, but screening of healthy individuals was recommended in Sicily, and not in Sweden. One hundred and fifty-three general practitioners in Sicily and 120 in Stockholm, 211 internists in Sicily and 83 in Stockholm participated. Main outcome measures were management policies for investigation and treatment and also attitudes. Routine lipid checks at first visits were done by few doctors in Stockholm but by a majority in Sicily (p < 0.001); in the presence of general cardiovascular risk factors (other than heredity, diabetes, cardiovascular disease and hypertension), routine checks were carried out more often by both general practitioners (p < 0.001) and internists (p < 0.005) in Stockholm. Drug treatment was initiated at lower cholesterol levels for secondary and primary intervention, cardiovascular disease, cardiovascular risk factors and hereditary hyperlipidaemia by both groups in Sicily (p < 0.001), as was dietary treatment. Secondary prevention was considered important by all groups, but primary prevention only by Sicilian doctors. We concluded that there were differences in views and management practice between doctors in Sicily and in Stockholm on the investigation and treatment of patients with hyperlipidaemia. Doctors tested lipids at first visits in Sicily but not in Stockholm. Treatment was initiated at lower levels of cholesterol in Sicily.
Similar content being viewed by others
References
Allhoff P, Lasser U. Management erhöhter Cholesterinwerte in der Praxis — Ergebnisse einer Befragung nicdergelassener Primärärzte. Klin Wochenschr 1989; 67: 1147–1151.
Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–1389.
Shepherd J, Cobbe S, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301–1307.
Sacks F, Pfeffer M, Moye L, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001–1009.
International Task Force for Prevention of Coronary Heart Disease. Prevention of coronary heart disease: Scientific background and new clinical guidelines. Recommendations of the European Atherosclerosis Society. Nutrition, Metabolism and Cardiovascular Diseases 1992; 2: 113–156.
National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 1994; 89: 1329–1345.
Pyorala K, Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice: Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Atherosclerosis 1994; 110: 121–161.
Beermann B, Strandberg K, Madsen S, Waersted A, Westbye O, eds. Treatment of hyperlipidaemia. Uppsala, Sweden: National Board of Health and Welfare, Drug information committee, 1996. Workshop; Vol 2.
Poli A, Laurenzi M. When are blood cholesterol and triglycerides elevated? A survey of 35,025 Italian physicians. Cardiovascular Risk Factors 1990; 1: 21–24.
Schucker B, Wittes J, Cutler J, et al. Change in physicians perspective on cholesterol and heart disease. JAMA 1987: 258: 3521.
Schucker B, Wittes J, Santanello N, et al. Change in cholesterol awareness and action. Results from national physician and public surveys. Arch Intern Med 1991; 151: 666–673.
Trocin M, Rastam L, Selander S. Dissemination and implementation of guidelines for lipid lowering. Fam Pract 1991; 8: 223–228.
Jonsson P, Högberg M, Lepisk J. Kolesterolsänkande läkemedel. Praxis och ekonomi (Cholesterol lowering drugs. Practice and economy). Stockholm: 1992, Spri-rapport 335. (In Swedish).
Danielsson B, Åberg H. Hyperlipidacmia — Management and views amongst physicians in general practice, in occupational health care and in internal medicine. J Intern Med 1993; 234: 411–416.
Lewis C, Howard D, Moulds R, Mashford M. Assessment of general practitioners management of hyperlipidaemia. A study using personal visits, and a scenario-based questionnaire. Aust Fam Physician 1994; 10: 1934, 1937–1941.
Troein M, Råstam L, Selander S. Reported treatment of hypercholesterolaemia by family physicians in Sweden and Minnesota. Am J Prev Med 1995; 11: 324–328.
Shepherd J, Pratt M. Prevention of coronary heart disease in clinical practice: A commentary on current treatment patterns in six European countries in relation to published recommendations. Cardiology 1996; 87: 1–5.
Strandberg K, Beermann B, Lönnerholm G, eds. Treatment of hyperlipidaemia. Uppsala, Swden: National Board of Health and Welfare, Drug information committee, 1989. (vol Workshop series).
Gustafsson L. A program system for statistical and epidemiological data analysis. University of Umeá, 1990.
Vancheri F, Alletto M, Burgio A, Fulco G, Paradiso R, Piangiamore M. Incidenza della ischemia encefalica acuta e analisi degli indicatori di rischio in una comunita a economia agricola. Recenti Prog Med 1994; 85: 355–361.
Averna M, Barbagallo C, Montalto G, et al. Progetto di epidemiologia e prevenzione ‘Ventimiglia di Sicilia’: distribuzione dei lipidi e delle apoproteine plasmatiche e prevalenza di dislipidemie. Giornale della Arteriosclerosi 1995; 20: 29–35.
Jungner J, Walldius G, Holme I, Kolar W, Steiner E. Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43,000 Swedish males and females. Int J Clin Lab Res 1992; 21: 247–255.
Nilsson J-E, Lanke J, Nilsson-Ehle P, Tryding N, Scherstén B. Reference intervals and decision limits for plasma lipids and lipoproteins: A practical evaluation of current recommendations. Scand J Clin Lab Invest 1994; 54: 137–146.
Boström G, Engqvist M, Olsson K, eds. Hur már Sverige? 1992 (How is Sweden?) Computer based program. Stockholm: Epidemiologic Centre, National Board of Health and Welfare, 1995.
Capocaccia R, Farchi G, Mariotti S, et al. La mortalità in Italia nell'anno 1991. Rome: Istituto Superiore di Sunità, 1995.
Lomas M, Anderson G, Deminick-Pierre K, Vayda E, Enkin M, Hannah W. Do practice guidelines guide practice? N Engl J Med 1989; 321: 1306–1311.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Danielsson, B., Åberg, H. & Strender, LE. Hyperlipidaemia: Differences in management practices and attitudes in two regions in Europe – Sicily and the Stockholm area. Eur J Epidemiol 14, 477–482 (1998). https://doi.org/10.1023/A:1007438108958
Issue Date:
DOI: https://doi.org/10.1023/A:1007438108958